Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

134.76
+0.00500.00%
Volume:215.08K
Turnover:28.98M
Market Cap:10.15B
PE:-31.05
High:134.81
Open:134.79
Low:134.71
Close:134.75
52wk High:134.88
52wk Low:35.39
Shares:75.34M
Float Shares:58.14M
Volume Ratio:0.50
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3400
EPS(LYR):-4.2155
ROE:-32.46%
ROA:-20.30%
PB:8.50
PE(LYR):-31.97

Loading ...

Apogee Therapeutics Announces Upcoming Board Resignations, Governance Shift

TIPRANKS
·
Apr 25

Apogee Therapeutics CFO Jane Henderson disposes 2,000 shares worth $180,000

Reuters
·
Apr 18

Apogee CEO Michael Henderson disposes of USD 1.7 million common shares

Reuters
·
Apr 11

Apogee Therapeutics (APGE) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Apr 06

Apogee CMO Carl Dambkowski disposes of USD 0.5 million common shares

Reuters
·
Apr 04

Apogee CFO Jane Henderson disposes of $0.2 million common shares

Reuters
·
Apr 04

Why Delta, Starbucks and these other stocks were just added to a market-beating 'fresh money' list

Dow Jones
·
Apr 02

Guggenheim Keeps Their Buy Rating on Apogee Therapeutics (APGE)

TIPRANKS
·
Mar 31

APGE: Best-in-Class Potential for Zumilokibart in Atopic Dermatitis Supports Undervalued Buy Rating

TIPRANKS
·
Mar 31

Should Apogee Therapeutics’ (APGE) Infrequent-Dosing AD Data and $403M Equity Raise Require Investor Action?

Simply Wall St.
·
Mar 31

Apogee Therapeutics Is Maintained at Outperform by Mizuho

Dow Jones
·
Mar 30

Mizuho Lifts Price Target on Apogee Therapeutics to $110 From $105, Keeps Outperform Rating

MT Newswires Live
·
Mar 30

U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan

Reuters
·
Mar 30

Apogee Therapeutics; CFO Jane Henderson drops 2,000 common shares for $170,000

Reuters
·
Mar 28

Apogee Therapeutics closes follow-on offering; gross proceeds rise to $403 million

Reuters
·
Mar 27

Press Release: Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $403 Million

Dow Jones
·
Mar 27

Apogee Therapeutics Prices Upsized Public Equity Offering

TIPRANKS
·
Mar 26

Apogee Therapeutics 5M share Secondary priced at $70.00

TIPRANKS
·
Mar 25

Apogee Therapeutics prices USD 350 million follow-on offering at USD 70 per share

Reuters
·
Mar 25

Apogee Therapeutics Inc - Prices 5 Mln Share Public Offering at $70.00 per Share

THOMSON REUTERS
·
Mar 25